Zhaoke Ophthalmology Limited (stock code 06622) reported its monthly return for the period ended 31 October 2025. The company maintains an authorised share capital of 1,600,000,000,000 ordinary shares at a par value of USD 0.00000025, totaling USD 400,000. No changes were recorded during the month, leaving the total issued shares at 547,955,012 with no treasury shares.

Regarding share options, four schemes remained in effect. The Pre-IPO scheme retained 26,575,516 options outstanding, with 25,157,816 shares potentially issuable or transferable. Three Post-IPO schemes adopted on 1 April 2021 also reported no new exercises in October. As of the end of the month, the first Post-IPO grant (December 15, 2022) showed 5,200,500 options outstanding, with 986,500 shares potentially issuable or transferable. The second Post-IPO grant (July 3, 2024) had 4,099,500 options outstanding and 1,814,500 shares potentially issuable. The most recent Post-IPO grant (September 8, 2025) reported 8,000,000 options outstanding, with 375,000 shares potentially issuable.

No warrants, convertibles, or other share issuances were reported for the period, and there was no movement in treasury shares.